486 related articles for article (PubMed ID: 33984802)
1. Dual-target compounds for Alzheimer's disease: Natural and synthetic AChE and BACE-1 dual-inhibitors and their structure-activity relationship (SAR).
Ferreira JPS; Albuquerque HMT; Cardoso SM; Silva AMS; Silva VLM
Eur J Med Chem; 2021 Oct; 221():113492. PubMed ID: 33984802
[TBL] [Abstract][Full Text] [Related]
2. Searching for the Multi-Target-Directed Ligands against Alzheimer's disease: discovery of quinoxaline-based hybrid compounds with AChE, H₃R and BACE 1 inhibitory activities.
Huang W; Tang L; Shi Y; Huang S; Xu L; Sheng R; Wu P; Li J; Zhou N; Hu Y
Bioorg Med Chem; 2011 Dec; 19(23):7158-67. PubMed ID: 22019465
[TBL] [Abstract][Full Text] [Related]
3. Design and synthesis of donepezil analogues as dual AChE and BACE-1 inhibitors.
Gabr MT; Abdel-Raziq MS
Bioorg Chem; 2018 Oct; 80():245-252. PubMed ID: 29966870
[TBL] [Abstract][Full Text] [Related]
4. Novel small molecule therapeutic agents for Alzheimer disease: Focusing on BACE1 and multi-target directed ligands.
Iraji A; Khoshneviszadeh M; Firuzi O; Khoshneviszadeh M; Edraki N
Bioorg Chem; 2020 Apr; 97():103649. PubMed ID: 32101780
[TBL] [Abstract][Full Text] [Related]
5. Design, synthesis, and biological evaluation of some 2-(3-oxo-5,6-diphenyl-1,2,4-triazin-2(3H)-yl)-N-phenylacetamide hybrids as MTDLs for Alzheimer's disease therapy.
Waiker DK; Verma A; Gajendra TA; Namrata ; Roy A; Kumar P; Trigun SK; Srikrishna S; Krishnamurthy S; Davisson VJ; Shrivastava SK
Eur J Med Chem; 2024 May; 271():116409. PubMed ID: 38663285
[TBL] [Abstract][Full Text] [Related]
6. Structure-based design, synthesis, and evaluation of structurally rigid donepezil analogues as dual AChE and BACE-1 inhibitors.
Gabr MT; Abdel-Raziq MS
Bioorg Med Chem Lett; 2018 Sep; 28(17):2910-2913. PubMed ID: 30017317
[TBL] [Abstract][Full Text] [Related]
7. Dynamic Simulation, Docking and DFT Studies Applied to a Set of Anti-Acetylcholinesterase Inhibitors in the enzyme β-Secretase (BACE-1): An Important Therapeutic Target in Alzheimer`s disease.
Silva-Junior EF; Barcellos Franca PH; Quintans-Junior LJ; Mendonca-Junior FJB; Scotti L; Scotti MT; de Aquino TM; de Araujo-Junior JX
Curr Comput Aided Drug Des; 2017 Nov; 13(4):266-274. PubMed ID: 28382866
[TBL] [Abstract][Full Text] [Related]
8. Structural determinants of the multifunctional profile of dual binding site acetylcholinesterase inhibitors as anti-Alzheimer agents.
Galdeano C; Viayna E; Arroyo P; Bidon-Chanal A; Blas JR; Muñoz-Torrero D; Luque FJ
Curr Pharm Des; 2010; 16(25):2818-36. PubMed ID: 20698824
[TBL] [Abstract][Full Text] [Related]
9. New neurogenic lipoic-based hybrids as innovative Alzheimer's drugs with σ-1 agonism and β-secretase inhibition.
Estrada M; Pérez C; Soriano E; Laurini E; Romano M; Pricl S; Morales-García JA; Pérez-Castillo A; Rodríguez-Franco MI
Future Med Chem; 2016 Jul; 8(11):1191-207. PubMed ID: 27402296
[TBL] [Abstract][Full Text] [Related]
10. Multipotent AChE and BACE-1 inhibitors for the treatment of Alzheimer's disease: Design, synthesis and bio-analysis of 7-amino-1,4-dihydro-2H-isoquilin-3-one derivates.
Zhao XJ; Gong DM; Jiang YR; Guo D; Zhu Y; Deng YC
Eur J Med Chem; 2017 Sep; 138():738-747. PubMed ID: 28728106
[TBL] [Abstract][Full Text] [Related]
11. Design, synthesis and biological Evaluation of Dual acetyl cholinesterase and beta-secretase inhibitors in treatment for alzheimer's Disease.
Deng Y; Jiang Y; Zhao X; Wang J
Pak J Pharm Sci; 2019 Sep; 32(5):2091-2098. PubMed ID: 31813875
[TBL] [Abstract][Full Text] [Related]
12. Dual Inhibitors of AChE and BACE-1 for Reducing Aβ in Alzheimer's Disease: From In Silico to In Vivo.
Stern N; Gacs A; Tátrai E; Flachner B; Hajdú I; Dobi K; Bágyi I; Dormán G; Lőrincz Z; Cseh S; Kígyós A; Tóvári J; Goldblum A
Int J Mol Sci; 2022 Oct; 23(21):. PubMed ID: 36361906
[TBL] [Abstract][Full Text] [Related]
13. Sarsasapogenin: A steroidal saponin from Asparagus racemosus as multi target directed ligand in Alzheimer's disease.
Kashyap P; Muthusamy K; Niranjan M; Trikha S; Kumar S
Steroids; 2020 Jan; 153():108529. PubMed ID: 31672628
[TBL] [Abstract][Full Text] [Related]
14. [Design of acetylcholinesterase inhibitor for Alzheimer's disease therapy: from multi-binding site inhibitors to multi-target directed ligands].
Yang WC; Sun Q; Yu NX; Zhu XL; Yang GF
Yao Xue Xue Bao; 2012 Mar; 47(3):313-21. PubMed ID: 22645754
[TBL] [Abstract][Full Text] [Related]
15. Lead optimization based design, synthesis, and pharmacological evaluation of quinazoline derivatives as multi-targeting agents for Alzheimer's disease treatment.
Verma A; Waiker DK; Singh N; Singh A; Saraf P; Bhardwaj B; Kumar P; Krishnamurthy S; Srikrishna S; Shrivastava SK
Eur J Med Chem; 2024 May; 271():116450. PubMed ID: 38701714
[TBL] [Abstract][Full Text] [Related]
16. Design, synthesis and biological evaluation of novel dual inhibitors of acetylcholinesterase and beta-secretase.
Zhu Y; Xiao K; Ma L; Xiong B; Fu Y; Yu H; Wang W; Wang X; Hu D; Peng H; Li J; Gong Q; Chai Q; Tang X; Zhang H; Li J; Shen J
Bioorg Med Chem; 2009 Feb; 17(4):1600-13. PubMed ID: 19162488
[TBL] [Abstract][Full Text] [Related]
17. Design and development of multitarget-directed N-Benzylpiperidine analogs as potential candidates for the treatment of Alzheimer's disease.
Sharma P; Tripathi A; Tripathi PN; Prajapati SK; Seth A; Tripathi MK; Srivastava P; Tiwari V; Krishnamurthy S; Shrivastava SK
Eur J Med Chem; 2019 Apr; 167():510-524. PubMed ID: 30784883
[TBL] [Abstract][Full Text] [Related]
18. Recent Studies on Design and Development of Drugs Against Alzheimer's Disease (AD) Based on Inhibition of BACE-1 and Other AD-causative Agents.
Gupta SP; Patil VM
Curr Top Med Chem; 2020; 20(13):1195-1213. PubMed ID: 32297584
[TBL] [Abstract][Full Text] [Related]
19. A review on flavonoid-based scaffolds as multi-target-directed ligands (MTDLs) for Alzheimer's disease.
Jalili-Baleh L; Babaei E; Abdpour S; Nasir Abbas Bukhari S; Foroumadi A; Ramazani A; Sharifzadeh M; Abdollahi M; Khoobi M
Eur J Med Chem; 2018 May; 152():570-589. PubMed ID: 29763806
[TBL] [Abstract][Full Text] [Related]
20. Dual targeting of acetylcholinesterase and tau aggregation: Design, synthesis and evaluation of multifunctional deoxyvasicinone analogues for Alzheimer's disease.
Manzoor S; Gabr MT; Rasool B; Pal K; Hoda N
Bioorg Chem; 2021 Nov; 116():105354. PubMed ID: 34562674
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
